CN103340949B - Eye drops for removing nebula and cataract - Google Patents
Eye drops for removing nebula and cataract Download PDFInfo
- Publication number
- CN103340949B CN103340949B CN201310288415.9A CN201310288415A CN103340949B CN 103340949 B CN103340949 B CN 103340949B CN 201310288415 A CN201310288415 A CN 201310288415A CN 103340949 B CN103340949 B CN 103340949B
- Authority
- CN
- China
- Prior art keywords
- parts
- cataract
- eye drops
- removing nebula
- chalcanthitum
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
The invention belongs to the field of traditional Chinese medicines and relates to eye drops for removing nebula and cataract. The eye drops are mainly prepared from bluestone, dried alum, mirabilite, smoked plum and coptis chinensis by combination in certain weight parts. The eye drops are suitable for treating eye diseases such as muscae volitantes, cataract, pterygium, pterygium, trachoma, keratitis, presbyopia and the like. Proved by clinical tests, the eye drops have an effective rate as high as 98%, realize remarkable treatment effects, need no surgery, cause no relapse, and relieve the pain and burthen of the patients.
Description
Technical field
The invention belongs to technical field of Chinese medicines, relate to a kind of medicament for the eyes, specifically a kind of removing nebula barrier eye liquid that disappears.
Background technology
Cataract, muscae volitantes, nebula shape pterygium is the commonly encountered diseases of ophthalmology, existing curative effect of medication is poor, how by operative treatment, easily bounce-back.
Summary of the invention,
The object of this invention is to provide a kind of removing nebula barrier eye liquid that disappears, by Drug therapy of the present invention, can eliminate symptom, recover vision, alleviate patient's misery and financial burden.
The present invention develops a kind of removing nebula barrier eye liquid that disappears, and adopts following weight portion medicine to be prepared from: Chalcanthitum 2-8 divides, Alumen 2-8 part, Natrii Sulfas 1-7 part, Fructus Mume 2-9 part, Rhizoma Coptidis 3-10 part.
The present invention selects Chalcanthitum, Alumen, Natrii Sulfas, Fructus Mume, Rhizoma Coptidis to be combined, and each efficacy of drugs produces synergism, the detoxification that relieves inflammation or internal heat, and dissipating blood stasis putrefaction removing, treats cataract effectively, muscae volitantes, the ophthalmic diseasess such as nebula shape pterygium.
The present invention adopts a kind of removing nebula prepared by said medicine barrier eye liquid that disappears, and compared with prior art, has the removing nebula barrier that disappears, and does not perform the operation, and does not rebound, and more effectively treats cataract, muscae volitantes, nebula shape bulbar conjunctiva polyp, climbs the remarkable advantage of the ophthalmic diseasess such as eyeball.
The specific embodiment
The present invention adopts following weight portion medicine to be prepared from: Chalcanthitum 2-8 part, Alumen 2-8 part, Natrii Sulfas 1-7 part, Fructus Mume 3-9 part, Rhizoma Coptidis 3-10 part.
The present invention adopts following weight portion medicine to be prepared from: Chalcanthitum 4-6 part, Alumen 4-6 part, Natrii Sulfas 3-5 part, Fructus Mume 5-7 part, Rhizoma Coptidis 5-8 part.
The embodiment of the present invention 1, adopts following weight portion medicine to be prepared from: 2 parts, Chalcanthitum, 2 parts of Alumen, 1 part, Natrii Sulfas, 3 parts of Fructus Mumes, 3 parts of Rhizoma Coptidis.
The embodiment of the present invention 2, adopts following weight portion medicine to be prepared from: 8 parts, Chalcanthitum, 8 parts of Alumen, 7 parts, Natrii Sulfas, 9 parts of Fructus Mumes, 10 parts of Rhizoma Coptidis.
The embodiment of the present invention 3, adopts following weight portion medicine to be prepared from: 4 parts, Chalcanthitum, 4 parts of Alumen, 3 parts, Natrii Sulfas, 5 parts of Fructus Mumes, 5 parts of Rhizoma Coptidis.
The embodiment of the present invention 4, adopts following weight portion medicine to be prepared from: 6 parts, Chalcanthitum, 6 parts of Alumen, 5 parts, Natrii Sulfas, 7 parts of Fructus Mumes, 8 parts of Rhizoma Coptidis.
The embodiment of the present invention 5, adopts following weight portion medicine to be prepared from: 5 parts, Chalcanthitum, 5 parts of Alumen, 4 parts, Natrii Sulfas, 6 parts of Fructus Mumes, 6 parts of Rhizoma Coptidis.
Preparation method:
Get it filled according to said medicine weight proportion, with cold water immersion 5-10 day, get the clear liquor of soaking medicated liquid, filling bottle packing.
Subject range:
1, particularly suitable muscae volitantes, cataract, nebula shape bulbar conjunctiva polyp, climbs eyeball;
2, be also suitable for trachoma, presbyopia, glaucoma, keratitis, epiphora induced by wind etc.
Using method:
External.To secondary, rinse outside ophthalmic with a cup (approximately 30 milliliters) eye liquid of the present invention before sleep every day one.
Clinical observation
1, physical data
Patient's 270 examples are controlled in examination altogether, wherein muscae volitantes 30 examples, and cataract 12 examples, nebula shape pterygium 54 examples, trachoma 31 examples, other 16 example, totally 143 examples, as treatment group, give liquid medicine applying of the present invention; Matched group 127 examples, treat at hospital ophthalmology by existing Therapeutic Method.
2, diagnostic criteria
Determine disease according to ophthalmic diagnosis standard or according to ophthalmic diagnosis result.
3, Therapeutic Method
Every day 1-2 time, each 1 cup (approximately 30 milliliters) medicinal liquid of the present invention, rinses outside ophthalmic external 3-6 month before sleep.
4, efficacy assessment standard
According to the efficacy assessment standard of disease described in ophthalmology or be efficacy assessment standard according to ophthalmology to described disease curative effect check result.
5, interpretation of result
Treatment group 143 examples, wherein muscae volitantes 30 examples are all cured, and cataract 12 examples, transfer 1.0 visions to by blind operation; Nebula shape bulbar conjunctiva polyp, climb that eyeball 54 example is basic to disappear; Trachoma 31 examples, all cure; Other 16 example, removes as presbyopia is with 400 degree glasses, and glaucoma recovers vision.Total effective rate 98%.
Matched group 127 examples, through treating at hospital ophthalmology by existing Therapeutic Method, as cataract 16 examples, nebula shape pterygium 59 examples, medicine is invalid, and all operative treatment is effective, year bounce-back half a year to 2, muscae volitantes 35 examples, the poor effect of medicine, 17 examples such as other trachoma, keratitis are effective, total effective rate 70%.
Therefrom find out that treatment group curative effect is apparently higher than matched group.
6, model case
1) open × ×, female, 59 years old, live Changzhuang, Wancheng District, Nanyang, suffer from cataract, muscae volitantes, climbs eyeball, glaucoma, trachoma, with medicinal liquid of the present invention more than four months, above disease is all cured.
2) Jiang × ×, man, 69 years old, live village, 20 li, the Lihe River township, Wancheng District, Nanyang, suffer from double blank cataract, keratitis, treats through three wheat harvesting periods with medicinal liquid of the present invention, and cataract, keratitis are fully recovered.
3) Liu × ×, female, 65 years old, live Baihe village, Baihe town, Wancheng District, Nanyang, suffer from cataract, climb eyeball, to treat through 3 wheat harvesting periods with medicinal liquid of the present invention, cataract is fully recovered, and vision reaches 0.8 by 0.2.Climb eyeball and substantially disappear, still continue medication.
4) often × ×, man, 67 years old, live tank factory of Nanyang Beijing Road, suffer from double blank cataract, through medicine of the present invention treatment in 5 months, vision reaches 0.5 by 0.1.
5) season × ×, man, 58 years old, live the Pu Shan Zhen Yang village, Wolong District, Nanyang, suffer from cataract, climb eyeball and presbyopia, through medicine of the present invention 6 months treatment, cataract, climb eyeball recovery from illness.
Claims (7)
1. the removing nebula barrier eye liquid that disappears, is characterized in that adopting following weight portion medicine to be prepared from:
Chalcanthitum 2-8 part, dried Alumen 2-8 part, Natrii Sulfas 1-7 part, Fructus Mume 2-9 part, Rhizoma Coptidis 3-10 part.
2. according to the removing nebula of the claim 1 barrier eye liquid that disappears, it is characterized in that adopting following weight portion medicine to be prepared from:
Chalcanthitum 4-6 part, dried Alumen 4-6 part, Natrii Sulfas 3-5 part, Fructus Mume 5-7 part, Rhizoma Coptidis 5-8 part.
3. according to the removing nebula of the claim 1 barrier eye liquid that disappears, it is characterized in that adopting following weight portion medicine to be prepared from:
2 parts, Chalcanthitum, 2 parts of dried Alumens, 1 part, Natrii Sulfas, 3 parts of Fructus Mumes, 3 parts of Rhizoma Coptidis.
4. according to the removing nebula of the claim 1 barrier eye liquid that disappears, it is characterized in that adopting following weight portion medicine to be prepared from:
8 parts, Chalcanthitum, 8 parts of dried Alumens, 7 parts, Natrii Sulfas, 9 parts of Fructus Mumes, 10 parts of Rhizoma Coptidis.
5. according to the removing nebula of the claim 1 barrier eye liquid that disappears, it is characterized in that adopting following weight portion medicine to be prepared from:
4 parts, Chalcanthitum, 4 parts of dried Alumens, 3 parts, Natrii Sulfas, 5 parts of Fructus Mumes, 5 parts of Rhizoma Coptidis.
6. according to the removing nebula of the claim 1 barrier eye liquid that disappears, it is characterized in that adopting following weight portion medicine to be prepared from:
6 parts, Chalcanthitum, 6 parts of dried Alumens, 5 parts, Natrii Sulfas, 7 parts of Fructus Mumes, 8 parts of Rhizoma Coptidis.
7. according to the removing nebula of the claim 1 barrier eye liquid that disappears, it is characterized in that adopting following weight portion medicine to be prepared from:
5 parts, Chalcanthitum, 5 parts of dried Alumens, 4 parts, Natrii Sulfas, 6 parts of Fructus Mumes, 6 parts of Rhizoma Coptidis.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310288415.9A CN103340949B (en) | 2013-07-10 | 2013-07-10 | Eye drops for removing nebula and cataract |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310288415.9A CN103340949B (en) | 2013-07-10 | 2013-07-10 | Eye drops for removing nebula and cataract |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN103340949A CN103340949A (en) | 2013-10-09 |
| CN103340949B true CN103340949B (en) | 2014-07-02 |
Family
ID=49275809
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201310288415.9A Expired - Fee Related CN103340949B (en) | 2013-07-10 | 2013-07-10 | Eye drops for removing nebula and cataract |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103340949B (en) |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN100389819C (en) * | 2006-06-09 | 2008-05-28 | 李金山 | Chinese-medicine for treating cataracta ophthalmopathy |
| CN101721556B (en) * | 2008-10-22 | 2012-06-13 | 谢建华 | Medicament composition with anti-inflammatory function and preparation method thereof |
-
2013
- 2013-07-10 CN CN201310288415.9A patent/CN103340949B/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| CN103340949A (en) | 2013-10-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102579991B (en) | Traditional Chinese medicine composition for treating herpes simplex viral keratitis | |
| CN103340949B (en) | Eye drops for removing nebula and cataract | |
| CN104587257A (en) | Traditional Chinese medicine composition for treating diabetic macular edema | |
| CN102198227B (en) | Method for preparing Chinese medicine for treating yin-deficiency glaucoma | |
| CN104208295A (en) | Medicine for treating scalds | |
| CN103479970A (en) | External medicine for treating rheumatic arthralgia | |
| CN103263598B (en) | Chinese medicine preparation for treating peripheral facial paralysis diseases | |
| CN102813754B (en) | Traditional Chinese medicine plaster for treating arthritis | |
| CN104324290A (en) | Traditional Chinese medicine composition for treating pityriasis rosea | |
| CN104258295A (en) | Traditional Chinese medicine decoction for treating lymphoma | |
| CN105079290B (en) | Compositions purposes in the medicine of preparation treatment acute cholecystitis | |
| CN102579724B (en) | Chinese medicine composition for treating glaucoma | |
| CN103120789A (en) | Traditional Chinese medicine composition for treating migraine | |
| CN104013880B (en) | It is a kind of to treat Chinese medicine composition of peritonitis and preparation method thereof | |
| CN103550357B (en) | A kind of control muscae volitantes collyrium and its production and use | |
| CN102552827B (en) | Medicine for treating epilepsy | |
| CN100371006C (en) | Chinese traditional medicine formula for curing cysticercosis | |
| CN105902918A (en) | Chinese medicinal composition for treating neck-shoulder-waist-leg pains | |
| CN103893637A (en) | Chinese medicinal lotion for treating verruca acuminata | |
| CN104873668A (en) | Traditional Chinese medicine composition for treating optic atrophy | |
| CN102441088B (en) | Traditional Chinese medicinal liquor used for treating lumbar muscle fiber inflammation | |
| CN103961466A (en) | Oral prescription for treating xerophthalmia | |
| CN102824546A (en) | Method for preparing Chinese medicinal lotion for treating closed fracture due to deficiency of kidney yin | |
| CN103550434B (en) | A kind of externally applied liniment for the treatment of rheumatism bone injury ache | |
| CN105663792A (en) | Traditional Chinese medicinal composition for treating paralytic strabismus |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20140702 Termination date: 20180710 |